Literature DB >> 19660823

HCV reinfection studies and the door to vaccine development.

Jason Grebely, David L Thomas, Gregory J Dore.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19660823     DOI： 10.1016/j.jhep.2009.07.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

1.  Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences.

Authors:  Claro Yu; Denali Boon; Shannon L McDonald; Timothy G Myers; Keiko Tomioka; Hanh Nguyen; Ronald E Engle; Sugantha Govindarajan; Suzanne U Emerson; Robert H Purcell
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

Review 2.  Hepatitis C virus vaccines among people who inject drugs.

Authors:  Andrea L Cox; David L Thomas
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

Review 3.  A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

4.  Can intranasal drug use reduce HCV infection among injecting drug users?

Authors:  Don C Des Jarlais; Holly Hagan; Kamyar Arasteh; Courtney McKnight; Salaam Semaan; David C Perlman
Journal:  Drug Alcohol Depend       Date:  2011-07-26       Impact factor: 4.492

Review 5.  Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Authors:  Jason Grebely; Maria Prins; Margaret Hellard; Andrea L Cox; William O Osburn; Georg Lauer; Kimberly Page; Andrew R Lloyd; Gregory J Dore
Journal:  Lancet Infect Dis       Date:  2012-05       Impact factor: 25.071

Review 6.  The prevention of infection-associated cancers.

Authors:  Silvio De Flora; Paolo Bonanni
Journal:  Carcinogenesis       Date:  2011-03-24       Impact factor: 4.944

7.  A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users.

Authors:  Arthur Y Kim; Ellen H Nagami; Christopher E Birch; Melinda J Bowen; Georg M Lauer; Barbara H McGovern
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

8.  The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.

Authors:  Peter Vickerman; Jason Grebely; Gregory J Dore; Rachel Sacks-Davis; Kimberly Page; David L Thomas; William O Osburn; Andrea L Cox; Campbell K Aitken; Matthew Hickman; Margaret Hellard
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

9.  Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.

Authors:  Rachel Sacks-Davis; Emma McBryde; Jason Grebely; Margaret Hellard; Peter Vickerman
Journal:  J R Soc Interface       Date:  2015-03-06       Impact factor: 4.118

10.  Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and Pegiviruses.

Authors:  Amit Kapoor; Arvind Kumar; Peter Simmonds; Nishit Bhuva; Lokendra Singh Chauhan; Bohyun Lee; Amadou Alpha Sall; Zhezhen Jin; Stephen S Morse; Beth Shaz; Peter D Burbelo; W Ian Lipkin
Journal:  MBio       Date:  2015-09-22       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.